Active	Status	Sponsor type	Region	Phase	Filter
13 Active 8 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Aboian, Mariam
NCT05655312: MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma	Recruiting	1/2	264	US	[203Pb]VMT01, [212Pb]VMT01, Nivolumab	Perspective Therapeutics	Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV, Mucosal Melanoma, Melanoma Stage III	12/27	12/29
NCT05553041: 18F-Fluciclovine PET-MRI in High-grade Glioma	Recruiting	1	30	US	18F-Fluciclovine PET-MRI, Axumin	Children's Hospital of Philadelphia, Blue Earth Diagnostics, Dragon Master Foundation	Glioma, High Grade Glioma, Glioma, Malignant, Glioma Intracranial, Diffuse Glioma	12/25	12/26
Matuskey, David
emo_to2, NCT06014385: PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor	Not yet recruiting	1	6	US	Scopolamine, [11C]EMO ([11C]LSN3172176)	Yale University, Janssen Scientific Affairs, LLC	Muscarinic Receptor Occupancy	07/25	07/25
Henry, Shannan
No trials found